These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29505206)

  • 1. Why co-infection may no longer be 'special'.
    Highleyman L
    Posit Aware; 2017; 29(1):28-9. PubMed ID: 29505206
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of acute and chronic HCV infection in persons with HIV coinfection.
    Sulkowski MS
    J Hepatol; 2014 Nov; 61(1 Suppl):S108-19. PubMed ID: 25443339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute hepatitis C in HIV coinfection: Is this a chance for achieving microelimination?
    Rockstroh J; Boesecke C
    United European Gastroenterol J; 2019 May; 7(4):465-466. PubMed ID: 31065363
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV/Hepatitis C Virus Co-infection among Adults Beginning Antiretroviral Therapy, Malawi.
    Demir M; Phiri S; Kaiser R; Chaweza T; Neuhann F; Tweya H; Fätkenheuer G; Steffen HM
    Emerg Infect Dis; 2016 Nov; 22(11):2018-2020. PubMed ID: 27767917
    [No Abstract]   [Full Text] [Related]  

  • 5. Human immunodeficiency virus and coinfection with hepatitis B and C.
    Petty LA; Steinbeck JL; Pursell K; Jensen DM
    Infect Dis Clin North Am; 2014 Sep; 28(3):477-99. PubMed ID: 25151567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Coinfection by human immunodeficiency virus and hepatitis C virus].
    Lana Soto R; Mendoza Hernández JL; Lérida Urteaga AI; Alvarez-Sala Walther JL
    Rev Clin Esp; 1998 Apr; 198(4):237-41. PubMed ID: 9633210
    [No Abstract]   [Full Text] [Related]  

  • 7. Micro-elimination of HIV and HCV co-infection.
    Dusheiko G; Childs K
    Lancet HIV; 2021 Feb; 8(2):e61-e62. PubMed ID: 33357836
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective.
    Peters L; Mocroft A; Lundgren J; Grint D; Kirk O; Rockstroh J
    BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S13. PubMed ID: 25253564
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C and HIV Coinfection for Social Workers in Public Health, Medical and Substance Use Treatment Settings.
    Sims OT; Womack BG
    Soc Work Public Health; 2015; 30(4):325-35. PubMed ID: 25811121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and features of chronic viral hepatitis and HIV coinfection in Italian prisons.
    Stasi C; Silvestri C; Fanti E; Di Fiandra T; Voller F
    Eur J Intern Med; 2016 Oct; 34():e21-e22. PubMed ID: 27189044
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV and hepatitis C virus co-infection in Kenya.
    Andonov A; Songok E; Ochwoto M; Osiowy C; Ball TB
    Lancet Infect Dis; 2015 Dec; 15(12):1377-8. PubMed ID: 26607120
    [No Abstract]   [Full Text] [Related]  

  • 13. [APRICOT Study evaluated. Surprisingly high virologic response in HIV-HCV coinfection].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():74-5. PubMed ID: 15373058
    [No Abstract]   [Full Text] [Related]  

  • 14. BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis C virus infection (2005).
    Nelson M; Matthews G; Brook MG; Main J; ;
    HIV Med; 2005 Jul; 6 Suppl 2():96-106. PubMed ID: 16011539
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV and hepatitis C coinfection.
    Matthews GV; Rockstroh J
    Curr Opin HIV AIDS; 2011 Nov; 6(6):449-50. PubMed ID: 22001889
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C virus reinfection after sustained virological response in HIV-infected patients with chronic hepatitis C.
    Pineda JA; Núñez-Torres R; Téllez F; Mancebo M; García F; Merchante N; Pérez-Pérez M; Neukam K; Macías J; Real LM;
    J Infect; 2015 Nov; 71(5):571-7. PubMed ID: 26212868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy.
    Hofer H; Aydin I; Neumueller-Guber S; Mueller C; Scherzer TM; Staufer K; Steindl-Munda P; Wrba F; Ferenci P
    J Viral Hepat; 2011 Jul; 18(7):513-7. PubMed ID: 20565572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hope for the eradication of HCV worldwide.
    Delfraissy JF
    Liver Int; 2013 Feb; 33 Suppl 1():198-9. PubMed ID: 23286866
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis C treatment in special patient groups].
    Berenguer M; Jorquera F; Ángel Serra M; Sola R; Castellano G
    Gastroenterol Hepatol; 2014 Jul; 37 Suppl 1():23-36. PubMed ID: 25907435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on a systematic review of randomized trials of peginterferon alpha-2a versus peginterferon alpha-2b in chronic hepatitis C.
    Singal AK; Jampana SC; Anand BS
    Hepatology; 2011 Jun; 53(6):2151. PubMed ID: 21538429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.